Skip to main content
Clinical Trials/JPRN-UMIN000001316
JPRN-UMIN000001316Unknown未知

Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancer - G-RAP Test

Faculty of Mediceine, University of Tokyo0 sites60 target enrollmentStarted: August 20, 2008Last updated:
Conditions

Trial Snapshot

Phase
未知
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Patients with gastric ulcer or esophagial varices 2 Lanza score, greater or equal 2 3 Direct invasion to gastric or duodenal mucosa 4 Patients who have the symptom of abdominal pain or heartburn 5 Patients who take NSAIDs or steroids 6 Patients who had taken PPI or H2RA within 14 days before start of chemothrapy 7 Patients who had liver chirrosis 8 Patients who ware given gastric resection 9 Performance status, greater or equal 3 10 Patients who had undertaken adverse event caused by PPI 11 Patients who were determined inadequate by doctor

Investigators

Sponsor
Faculty of Mediceine, University of Tokyo

Similar Trials

Multicenter randomized trial of the... | Clinical Trial